Tranexamic acid and intensive blood pressure for early brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a bleed in the upper part of your brain (not near the deep center) that is smaller than 40 mL and is still growing quickly.
- Your symptoms started within the last 2 hours, and you can be treated at the hospital within that time.
- Your top blood pressure number (systolic) is at least 150 but less than 220, and you have had at least two readings 2 minutes apart.
- You have moderate to severe symptoms (a stroke scale score of 8 or more, or weakness in one arm or leg).
- You are not on blood thinners and do not have any bleeding disorders or other conditions that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This Phase 3 study tests whether tranexamic acid (a medicine that helps blood clot) can stop a chronic subdural hematoma from getting worse. It’s for people diagnosed by CT who are being treated without surgery at first.
This trial studies whether tranexamic acid (a medicine that helps slow blood breakdown) can improve outcomes for people with symptomatic subdural hematoma—blood collecting between the brain and its outer covering. You may be able to join if you’re older, have bleeding seen on CT, symptoms linked to the bleed, and meet several safety and timing rules.
This trial tests if a medication called tranexamic acid can help treat chronic subdural hematomas (a type of bleeding on the brain) without surgery. It's for patients who have this condition but don't need immediate surgery.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can improve outcomes for children with certain serious head or torso injuries. It aims to reduce complications from internal bleeding when the medicine is given soon after the injury.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.